Evidence map›Paper›PMID 33831072›Full record

ArticlePloS one2021

Long-term outcome of prolonged critical illness: A multicentered study in North Brisbane, Australia.

Kevin B Laupland, Mahesh Ramanan, Kiran Shekar, Felicity Edwards, Pierre Clement, Alexis Tabah

Abstract readMulticenter Study
In one paragraph

Article in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Long-term survival of patients with persistent critical illness in Australia and New Zealand; a retrospective registry-based cohort study.Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. ICU-acquired hypernatremia: Prevalence, patient characteristics, trajectory, risk factors, and outcomes.Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine · 2024
    Article
  8. Point-of-care creatinine vs. central laboratory creatinine in the critically ill.Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine · 2024
    Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Kevin B LauplandDepartment of Intensive Care Services, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.ORCID 0000-0002-1205-5354
Mahesh RamananFaculty of Medicine, University of Queensland, Brisbane, Queensland, Australia.
Kiran ShekarFaculty of Medicine, University of Queensland, Brisbane, Queensland, Australia.
Felicity EdwardsQueensland University of Technology (QUT), Brisbane, Queensland, Australia.
Pierre ClementDepartment of Intensive Care Services, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.
Alexis TabahFaculty of Medicine, University of Queensland, Brisbane, Queensland, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAlthough critical illness is usually of high acuity and short duration, some patients require prolonged management in intensive care units (ICU) and suffer long-term morbidity and mortality.

objectiveTo describe the long-term survival and examine determinants of death among patients with prolonged ICU admission.

methodsA retrospective cohort of adult Queensland residents admitted to ICUs for 14 days or longer in North Brisbane, Australia was assembled. Comorbid illnesses were classified using the Charlson definitions and all cause case fatality established using statewide vital statistics.

resultsDuring the study a total of 28,742 adult Queensland residents had first admissions to participating ICUs of which 1,157 (4.0%) had prolonged admissions for two weeks or longer. Patients with prolonged admissions included 645 (55.8%), 243 (21.0%), and 269 (23.3%) with ICU lengths of stay lasting 14-20, 21-27, and ≥28 days, respectively. Although the severity of illness at admission did not vary, pre-existing comorbid illnesses including myocardial infarction, congestive heart failure, kidney disease, and peptic ulcer disease were more frequent whereas cancer, cerebrovascular accidents, and plegia were less frequently observed among patients with increasing ICU lengths of stay lasting 14-20, 21-27, and ≥28 days. The ICU, hospital, 90-day, and one-year all cause case-fatality rates were 12.7%, 18.5%, 20.2%, and 24.9%, respectively, and were not different according to duration of ICU stay. The median duration of observation was 1,037 (interquartile range, 214-1888) days. Although comorbidity, age, and admitting diagnosis were significant, neither ICU duration of stay nor severity of illness at admission were associated with overall survival outcome in a multivariable Cox regression model.

conclusionsMost patients with prolonged stays in our ICUs are alive at one year post-admission. Older age and previous comorbidities, but not severity of illness or duration of ICU stay, are associated with adverse long-term mortality outcome.

Indexed as

AdultAgedAustraliaComorbidityCritical IllnessFemaleHumansIntensive Care UnitsLength of StayMaleMiddle AgedMortalityPatient AdmissionSeverity of Illness Index

Identifiers

PMID33831072
PMCPMC8031082

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.